Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01793103 · ClinicalTrials.gov registry record
Brigham and Women's Rheumatoid Arthritis Sequential Study
A clinical trial of Rheumatoid Arthritis, sponsored by Brigham and Women's Hospital.
- Active
- Registry status
- 1,598
- Enrollment target
- 1
- Study location
NCT01793103: Active study of Rheumatoid Arthritis, sponsored by Brigham and Women's Hospital.
NCT01793103 is a study of Rheumatoid Arthritis that is active but no longer recruiting, run by Brigham and Women's Hospital. The registered enrollment target is 1,598 participants, below the 4,683-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01793103, a study of Rheumatoid Arthritis, is active but no longer recruiting, sponsored by Brigham and Women's Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- 1,598 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of the present study is to establish a prospective observational cohort of Rheumatoid Arthritis patients in order to 1. Determine and validate biomarkers that predict drug response and toxicity in RA. 2. Determine and validate biomarkers that predict disease activity and prognosis in RA. 3. Evaluate the natural history of treated RA in terms of its clinical, functional and economic outcomes.
Primary Outcome
Determine and validate biomarkers that predict drug response and toxicity in RA.
Conditions Studied
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,598 participants |
| Start Date | 2003-03 |
| Est. Completion | 2028-03 |
What the registry record for NCT01793103 still lists
NCT01793103 is an observational study that tracks outcomes without assigning an intervention. Its 1,598 participants enrollment target places it among the larger protocols in the corpus, below the 4,683-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (66% lower).
The record links to 1 condition, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 0 interventions.
NCT01793103 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01793103 about?
NCT01793103 is a clinical study titled "Brigham and Women's Rheumatoid Arthritis Sequential Study". The goal of the present study is to establish a prospective observational cohort of Rheumatoid Arthritis patients in order to 1. Determine and validate biomarkers that predict drug response and toxicity in RA. 2. Determine and validate biomarkers that predict disease activity and prognosis in RA. 3...
What is the current status of trial NCT01793103?
This trial is currently active not recruiting. The enrollment target is 1,598 participants. The study started on 2003-03. Estimated completion is 2028-03.
What conditions does trial NCT01793103 study?
This clinical trial studies the following conditions: Rheumatoid Arthritis.
Who is sponsoring clinical trial NCT01793103?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01793103 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rheumatoid Arthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01793103's enrollment target sits among peer trials
1,598 14th of 197 higher than 184 of 197 other Rheumatoid Arthritis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Rheumatoid Arthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Rheumatology Diet Study
RECRUITING
-
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
RECRUITING · Phase 1
-
EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))
RECRUITING · NA
-
Creating Health Course Study for People With Rheumatological Conditions
RECRUITING · NA
-
Physica System Total Knee Replacement Registry Study
RECRUITING · NA
-
Study of GS-0151 in Participants With Rheumatoid Arthritis
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00646022 · 1,600 participants
Natural History of Familial Carcinoid Tumor
- NCT03109197 · 1,600 participants
Sudden Unexplained Death in Childhood (SUDC) Registry
- NCT03511118 · 1,600 participants
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
- NCT04314401 · 1,600 participants
National Cancer Institute "Cancer Moonshot Biobank"
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia